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Abstract
Th17 cells have emerged as a key factor in the pathogenesis of uveitis as well as other autoimmune disorders. They secrete a
number of cytokines including IL-17A, IL-17F and IL-22 and until now the effects of these cytokines on resident cells of the
eye were not yet clear. The purpose of this study was to investigate the effects of Interleukin (IL)-17A, IL-17F and IL-22 on
the production of inflammatory mediators and barrier function of retinal pigment epithelium cells. We showed that ARPE-19
cells, a spontaneously arisen cell line of retinal pigment epithelium (RPE), constitutively expressed IL-17RC and IL-22R, but
not IL-17RA. IL-17A significantly enhanced the production of CXCL8, CCL2, CCL20 and IL-6 by these cells. IL-17F had a similar
effect on the production of CXCL8, CCL2 and IL-6 by ARPE-19 cells, but did not influence the expression of CCL20. Both IL-
17A and IL-17F significantly decreased the transepithelial electrical resistance (TER) of the ARPE-19 monolayer and increased
the diffusion rate of fluorescein isothiocyanate (FITC)-dextran. They also disrupted the distribution of the junction proteins
zonula occludens (ZO)-1 and occludin at the interface of adjacent cells. IL-22 did not have a detectable effect on the
production of the tested inflammatory mediators by ARPE-19 cells, TER of the ARPE-19 monolayer, the diffusion rate of FITC-
dextran or the distribution of ZO-1 and occludin. This study demonstrates that IL-17A and IL-17F, but not IL-22, significantly
promoted ARPE-19 cells to secrete inflammatory mediators and compromised the ARPE-19 monolayer barrier function in
association with a disrupted distribution of ZO-1 and occludin. These results suggest that both IL-17A and IL-17F may play a
role in posterior segment inflammation of the eye.
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Introduction
Th17 cells have been identified as a subset of T helper
lymphocytes characterized by the production of a number of
cytokines including Interleukin (IL)-17A, IL-17F and IL-22[1,2].
They have emerged as a key factor in the pathogenesis of uveitis as
well as other autoimmune disorders[3,4]. Growing evidence
suggests that Th17 cells trigger inflammatory responses primarily
via IL-17A[5], although IL-17F and IL-22 have also been shown
to be involved in the pathogenesis of autoimmune diseas-
es[6,7,8,9]. It has been well established that these cytokines exert
their role through an interaction with their receptors in certain
cells. IL-17RA is expressed ubiquitously with a higher level in
hemopoietic cells, whereas IL-17RC is mainly expressed by
nonhemopoietic cells in tissues such as adrenal gland, prostate,
liver and thyroid[10]. IL-22R is primarily expressed in epithelial
cells [11].
Recent studies have shown that IL-17A is involved in the
development of inflammation through promoting the production
of chemokines and proinflammatory cytokines including CXCL8,
CCL2 and IL-6[12]. IL-17F has biological activities similar to IL-
17A[13]. IL-22 has a weaker ability to induce the expression of
CXCL8, CCL2 and CCL20 by keratinocytes or endothelial
cells[8,14,15].
A recent study showed an increased expression of IL-17A
mRNA in the retina of mice with experimental autoimmune
uveoretinitis (EAU), a classical model for human autoimmune
uveitis[3]. IL-17A protein and IL-22 mRNA were found to be
highly expressed by peripheral blood mononuclear cells (PBMCs)
from uveitis patients[7,16,17]. However it is not yet known which
cells are the targets of these cytokines and how they function
within the eye during uveitis involving the posterior segment. It
has been well documented that the retinal pigment epithelium
(RPE) plays an important role in the maintenance of the ocular
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uveitis[18]. It has been shown that RPE could secrete a number
of chemokines and proinflammatory cytokines including CXCL8,
CCL2 and IL-6 in response to various stimulants[18]. These
inflammatory mediators produced by RPE are generally similar to
those produced via IL-17A and IL-17F stimulation[12,13,19].
This similarity stimulated us to investigate the effects of these
cytokines on ARPE-19, a spontaneously arisen cell line of RPE,
which has been extensively used in the past decades to investigate
the role of this cell layer in the pathogenesis of a number of
diseases including age related macular degeneration, vitreoretino-
pathies and uveitis. Our study revealed that ARPE-19 cells
constitutively expressed IL-17RC and IL-22R. IL-17A was able to
stimulate the production of CXCL8, CCL2, CCL20 and IL-6 by
ARPE-19 cells. IL-17F only stimulated the secretion of CXCL8,
CCL2 and IL-6 by these cells. Both IL-17A and IL-17F were able
to compromise the barrier function of the ARPE-19 monolayer in
association with a disrupted distribution of the tight junction
proteins zonula occludens (ZO)-1 and occludin.
Results
Expression of IL-22R, IL-17RC and IL-17RA by ARPE-19
Cells
Immunocytochemistry was used to detect IL-17RA, IL-17RC
and IL-22R expression by ARPE-19 cells. The results showed
that all cells expressed IL-17RC and IL-22R. The expression of
both IL-17RC and IL-22R was uniquely distributed on the
cellular membrane and in the cytoplasm but not in the
nucleus(Fig. 1A). IL-17RA expression was not detectable. There
was no staining in the isotype control experiments. Additional
experiments were performed to verify the absence of IL-17RA
using Western blot analysis and including PBMCs as a positive
control. The results confirmed our immunocytochemistry find-
ings and showed that ARPE-19 cells expressed only IL-17RC but
not IL-17RA(Fig. 1B). However, PBMCs expressed both IL-
17RA and IL-17RC.
The Influence of IL-17A, IL-17F and IL-22 on the
Production of Inflammatory Mediators by ARPE-19 Cells
To determine the influence of IL-17A, IL-17F and IL-22 on
the production of inflammatory mediators by ARPE-19 cells, the
expression of CXCL8, CCL2, CCL20, CXCL10 and IL-6 by
these cells was assayed. The results showed that IL-17A
significantly enhanced the production of CXCL8 (p,0.001),
CCL2 (p#0.001), CCL20 (p,0.001) and IL-6 (p,0.001), but
did not influence the production of CXCL10 (data not shown)
by these cells (Fig. 2). The stimulation of IL-17A on these
mediators appeared in a dose-dependent manner. IL-17F had a
similar, but somewhat weaker, stimulatory effect on the
production of CXCL8, CCL2 and IL-6 in a dose-dependent
manner. However it did not have any influence on the
production of CCL20 and CXCL10. CXCL8 production
induced by both IL-17A and IL-17F was the most prominent,
followed by IL-6 and CCL2. There was no effect of IL-22 on the
production of all the investigated inflammatory mediators at the
tested three concentrations.
The Influence of IL-17A, IL-17F and IL-22 on the Barrier
Integrity of the ARPE-19 Monolayer
The transepithelial electrical resistance (TER) and permeability
of the ARPE-19 monolayer was used to evaluate the influence of
IL-17A, IL-17F or IL-22 on the barrier integrity of the monolayer.
The result revealed that the TER of the ARPE-19 monolayer
grown on transwell filters increased rapidly during the initial 18
days of culture and reached a plateau within the following 3 days
(Fig. 3). A mean level of 45.066.0 V/cm
2 TER was recorded on
day 21. On day 21 the monolayer was stimulated with IL-17A, IL-
17F and IL-22 respectively for 7 days and the TER of the ARPE-
19 monolayer was measured every day during this time period. It
was found that IL-17A or IL-17F gradually decreased the TER,
and a significantly decreased TER occurred on day 5 (p=0.019,
p=0.045 respectively) and thereafter. The monolayer permeabil-
ity was further assayed by measuring the transepithelial diffusion
rate of fluorescein isothiocyanate (FITC)-dextran through the
ARPE-19 monolayer grown on the filters. A significantly increased
diffusion rate of FITC-dextran was observed when the cells were
cultured in the presence of IL-17A (p=0.01) or IL-17F (p=0.015)
(Fig. 4). We failed to find an influence of IL-22 on the TER and
permeability of the ARPE-19 monolayer.
The Influence of IL-17A, IL-17F and IL-22 on the
Expression of ZO-1 and Occludin
As the aforementioned experiment showed a compromised
barrier function following exposure to IL-17A and IL-17F, a
further study was performed to examine whether this abnormality
was associated with a disturbed distribution of ZO-1 and
occludin, two proteins critical to the barrier integrity. The results
showed that the expression of ZO-1 and occludin was continuous
and regular around the cells in the ARPE-19 monolayer cultured
alone. The exposure of these cells to IL-17A or IL-17F for 6 days
resulted in a markedly disturbed distribution of ZO-1 and
occludin. The abnormal distribution of ZO-1 typically manifested
as fragmental staining. The staining of occludin showed a diffuse
cytoplasmic distribution (Fig. 5). 49,6-diamidino-2-phenylindole
(DAPI) staining for nuclei showed the uniform distribution of
ARPE-19 cells over the monolayer. Exposure to IL-22 was
similar to that in the ARPE-19 monolayer cultured without any
stimuli.
Figure 1. Expression of IL-22R and IL-17RC in ARPE-19 cells. (A) Coexpression of IL-22R and IL-17RC in ARPE-19 cells was shown by
immunocytochemistry. Scale bar =75 mm. (B) Western blot revealed that ARPE-19 cells expressed only IL-17RC. However, PBMCs expressed both IL-
17RA and IL-17RC.
doi:10.1371/journal.pone.0018139.g001
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This study shows that ARPE-19 cells constitutively express IL-
17RC and IL-22R at the protein level. IL-17A and IL-17F, but
not IL-22, significantly stimulated ARPE-19 cells to secrete a
number of inflammatory mediators such as CXCL8, CCL2,
CCL20 and IL-6. Additionally IL-17A and IL-17F significantly
compromised the barrier function of the ARPE-19 monolayer and
disturbed the distribution of the tight junction proteins ZO-1 and
occludin in the ARPE-19 monolayer. Posterior segment inflam-
mation of the eye is accompanied by T cell infiltration and
recently the Th17 subpopulation has been implicated to play an
important role in the pathogenesis of this blinding condi-
tion[3,4,20]. Th17 cells secrete a number of cytokines including
IL-17A, IL-17F and IL-22[2] and until now the effects of these
cytokines on resident cells of the eye was not yet clear and was
therefore the subject of our study.
We showed that the ARPE-19 cells expressed IL-17RC and IL-
22R, but not IL-17RA, although IL-17RA is generally thought to
be essential for IL-17A function[21]. A recent study however
showed that IL-17RC was able to bind to both IL-17A and IL-17F
with a similar high affinity[10]. Our results were consistent with
earlier studies by Leung et al.[22] who found that ARPE-19 cells
and RPE cells from primary cultures (2nd–3rd passage) only
expressed IL-17RC mRNA, but definitely not IL-17RA mRNA.
Mouse RPE cells, on the other hand, do express IL-17RA[23].
This discrepancy could be explained by the origin of the RPE cells
used in the experiments. These findings suggest that ARPE-19
cells are one of the targets for IL-17A, IL-17F and IL-22. Both IL-
17A and IL-17F were able to profoundly stimulate the production
of CXCL8, CCL2 and IL-6 by ARPE-19 cells, albeit that on a
quantitative basis IL-17F was shown to be less active. CXCL-8
and CCL2 have been demonstrated as important chemokines for
neutrophils and monocytes respectively. IL-6 also has a variety of
proinflammatory biological activities and has been shown to play
an important role in the pathogenesis of inflammation[24]. This
result suggests that both IL-17A and IL-17F may be involved in
posterior segment inflammation of the eye through stimulation of
inflammatory cytokine production by the resident cell population.
It was interesting to note that IL-17A, but not IL-17F, upregulated
Figure 2. IL-17A and IL-17F but not IL-22 promoted chemokines and IL-6 production in ARPE-19 cells. Confluent ARPE-19 cells were
stimulated with different concentrations of IL-17A, IL-17F or IL-22 as indicated. After 24 hours of incubation, protein concentrations of CXCL8, CCL2,
CCL20 and IL-6 released into the supernatants were measured by ELISA. Data were shown as the means6SEM of four independent experiments.
**p,0.01 versus the control group.
doi:10.1371/journal.pone.0018139.g002
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of Th17 cells[25,26]. The inconsistent effects of IL-17A and IL-
17F were also observed by Zrioual et al. in human rheumatoid
arthritis synoviocytes[27]. They found that although both IL-17A
and IL-17F had similar chemokine inducing properties, the
activity of IL-17F was less powerful. It is worthwhile to point
out that IL-22 did not have a detectable effect on the production of
all the investigated cytokines at the three tested concentrations
although its receptor was expressed by these cells. A recent study
showed an increased expression of IL-22 by PBMCs from uveitis
patients, suggesting its possible involvement in this disease[7]. It is
not clear whether IL-22 could influence the production of these
aforementioned cytokines under other culture conditions or the
production of other cytokines by these ARPE-19 cells. More
studies are needed to clarify these issues.
As the integrity of the RPE barrier is critical for the interphase
between the retina and choroid, a further study was designed to
investigate whether IL-17A, IL-17F and IL-22 could break down
this barrier. TER has been widely used to evaluate the barrier
function of epithelium in vitro[28,29,30]. In the present study,
TER of the ARPE-19 monolayer gradually increased and reached
a plateau after 3 weeks of culture. Addition of IL-17A or IL-17F
resulted in a decrease of the TER of the ARPE-19 monolayer.
This result suggests that both cytokines could significantly
compromise the barrier function of the ARPE-19 monolayer.
Transepithelial fluxes of FITC-dextran, a test to evaluate the
structural integrity of cultured epithelium monolayers[30,31], was
also used in the present study. Exposure of IL-17A or IL-17F for 6
days resulted in a significantly increased diffusion rate as
compared to unstimulated controls. This result suggests that both
IL-17A and IL-17F had an effect on the structural integrity of the
monolayer. These alterations on TER and diffusion rate of FITC-
dextran were also reported previously when RPE were exposed to
IL-1b or to tumor necrosis factor-a combined with lipopolysac-
charide and interferon-c[28,29]. Interestingly we did not find any
effect of IL-22 on both TER or the diffusion rate of FITC-dextran.
This result, together with that observed in the cytokine study,
suggests that ARPE-19 cells may not be an important target of IL-
22 with respect to the production of the tested cytokines and the
influence on barrier function under the culture conditions
described in the present study. It is worthwhile to point out that
a decreased TER was reported in an experiment using human
fetal RPE cells in the presence of IL-22.[7]. Additionally,
induction of RPE cell apoptosis by IL-22 was also observed in
this study. The difference with regard to the TER results between
both studies may be, at least partially, explained by the different
origin of the target cells or rIL-22 used.
Barrier function of epithelium is brought about by intercellular
tight junctions, involving a number of tight junction proteins. ZO-
1 and occludin are considered as two important tight junction
proteins of the RPE cell layer and their expression was used to
correlate whether the breakdown of ARPE-19 monolayer barrier
function as found in this study was associated with an abnormal
distribution of both proteins. Correspondingly we found that both
IL-17A and IL-17F were able to disturb the distribution of these
two proteins. The abnormal distribution of both proteins caused
by IL-17A or IL-17F, although not completely similar, may lead to
a decreased TER and increased diffusion rate of FITC-dextran.
Similar to the results observed in the studies of cytokines, TER and
diffusion rate of FITC-dextran, IL-22 did not affect the
distribution of the tested two tight junction proteins.
In conclusion, the present study revealed the presence of IL-
17RC and IL-22R on cultured ARPE-19 cells. IL-17A and IL-17F
significantly increased the expression of a number of inflammatory
mediators by these cells. Both cytokines profoundly disturbed the
distribution of ZO-1 and occludin and consequently affected the
barrier function of the ARPE-19 monolayer. IL-22 influenced
neither the production of the tested cytokines, nor the barrier
function of the ARPE-19 cells. The exact mechanisms whereby
IL-17A and IL-17F affect the function of RPE cells needs to be
addressed in future studies. As the biological function of the
ARPE-19 cell line may be different from RPE in vivo, the in vitro
data shown in the study presented here need to be confirmed using
in vivo models
Materials and Methods
Cell Culture
Human ARPE-19 cells were obtained from the American type
culture collection (ATCC), and cells between passages 16 and 20
were used for experiments. The cells were cultured in 1:1 in
Figure 3. Effect of IL-17A, IL-17F or IL-22 on TER of cultured
ARPE-19 monolayer. Monolayers were cultured for 21 days, where
after the various stimuli were added. Incubation of ARPE-19 monolayers
with 50 ng/ml IL-17A or IL-17F induced a gradual decrease of TER, and a
significant effect occurred 5 days (p=0.019, p=0.045) after stimulation.
The continuous decreases were also observed 6 days (p=0.01,
p=0.016) and 7 days (p=0.023, p=0.008) after stimulation. IL-22 had
no effect on TER. Data were shown as the means6SEM of four
independent experiments. *p,0.05 versus the control group.
doi:10.1371/journal.pone.0018139.g003
Figure 4. Effect of IL-17A, IL-17F or IL-22 on transepithelial
diffusion rate of FITC-dextran in ARPE-19 monolayer. Stimula-
tion of ARPE-19 monolayer with 50 ng/ml IL-17A, IL-17F or IL-22 for 6
days induced a higher FITC-dextran diffusion rate at 24 hours compared
with the control group. A diffusion percentage approaching 100%
indicates that the amount of dextran-FITC in the upper and lower
chamber approaches the same values. IL-22 had no effect on diffusion
rate. Data were shown as the means6SEM of four independent
experiments. *p,0.05 versus the control group.
doi:10.1371/journal.pone.0018139.g004
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gen, Beijing, China) with 10% fetal bovine serum (FBS,
Invitrogen, Carlsbad, CA), 100 U/mL penicillin, and 100ı `g/ml
streptomycin in a humidified incubator at 37uCi n5 %C O 2. The
cells were passed every 4 to 5 days by trypsinization and were
seeded into Corning flasks at 1.2610
6 cells/flask, resulting in
complete confluent (<2610
6 cells/flask) cultures in 4 days. For
ARPE-19 monolayer culture, they were seeded at 2610
5 cells/cm
2
onto Transwell filters (Costar, 12 mm diameter, 0.4ı `ı `m pore size),
which had been coated with 160 ml of a 1:30 dilution of Matrigel
(BD Biosciences, Bedford, MA) in DMEM/F12 and air-dried
overnight. DMEM/F12 medium supplemented with 1% FBS was
used to culture these cells and was changed every 4 days.
Western blot
ARPE-19 cells and PBMCs were rinsed with ice-cold PBS and
cells were lysed with lysis buffer containing 50 mM Tris-HCl
(pH 7.4), 150 mM NaCl, 1% Triton X-100, 1% sodium
deoxycholate, 0.1% SDS, 2 mM EDTA, 100 mM phenylmethyl-
sulfonylfluoride. The cell lysate was centrifuged and supernatant
was collected. Protein concentration was determined with a
protein assay (Bio-Rad, Richmond, CA). Laemmli gel loading
buffer was added to the lysate and boiled for 7 minutes, after
which proteins were separated on an SDS- polyacrylamide gel.
Proteins were transferred to polyvinylidene difluoride membranes
(Millipore, Bedford, MA), blocked by 5% skim milk at 37uC for
2 hours, and incubated with the primary antibodies anti-IL-17RA,
anti-IL-17RC (Santa Cruz, CA) at 4uC for 16 hours, followed by a
horseradish peroxidase-conjugated secondary antibody at 37uC for
1 hour. The membranes were further developed using a
chemiluminescent detection kit (Cell Signaling Technology,
Beverly, MA).
Enzyme-Linked Immunosorbent Assay (ELISA)
ARPE-19 cells were maintained in DMEM/F12 medium
containing 10% FBS for 4 days to become confluent. Before
stimulation, cells were serum-starved for 24 hours in medium with
1% FBS. ARPE-19 cells were not stimulated (controls) or
stimulated with 10, 50 or 100 ng/ml recombinant IL-17A, IL-
17F or IL-22 (R&D Systems, Minneapolis, MN) for 24 hours. The
collected supernatants were centrifuged (1000 g X 5 minutes) to
remove particulates and stored at 270uC until analysis. CXCL8,
CCL2, CCL20, CXCL10 and IL-6 were measured using human
ELISA development kits (Duoset; R&D Systems, Minneapolis,
MN). Each stimulation experiment was repeated four times.
Measurement of TER
TER was measured using a commercial electrical resistance
system (Millicell; Millipore, Bedford, MA). All TER measurements
were performed within 3 min after removal of filters from the
incubator. Net TERs were calculated by subtracting the value of a
blank, Matrigel-coated filter without cells from the experimental
value. Final resistance-area products (V/cm
2) were obtained by
multiplying the net TERs by the effective growth area.
Measurements were performed every 3 days within the first 16
days and every other day or every day during the following
culture. After TER stabilization, the ARPE-19 monolayer was
incubated with or without one of various stimulants: IL-
17A(50 ng/ml), IL-17F(50 ng/ml) or IL-22(50 ng/ml). The me-
dium with or without stimulants was changed every other day.
Measurements were repeated at least four times for each filter, and
each experiment was repeated at least four times using 4 filters.
Permeability Assay
The paracellular permeability of the ARPE-19 monolayer was
evaluated by measuring the passive permeation of FITC-dextran
(4 kDa, Sigma-Aldrich, Shanghai, China) across confluent cells
grown on filters. Three weeks later, the ARPE-19 monolayer was
treated with IL-17A(50 ng/ml), IL-17F(50 ng/ml) or IL-
22(50 ng/ml) for 6 days. The medium was changed every 2 days,
and 1000 mg/ml FITC-dextran was added to the upper chamber
on day 6 following stimulation. Samples(100 ml) were taken from
the upper and lower chamber 24 hours after addition of FITC-
dextran. The concentration of FITC-dextran in these samples was
quantified by spectrophotometry. The diffusion rate was expressed
as a percentage and calculated as follows: (amount of dextran
Figure 5. Effect of IL-17A, IL-17F or IL-22 on the distribution of junction proteins in ARPE-19 monolayer. Cells were incubated with or
without 50 ng/ml IL-17A, IL-17F or IL-22 for 6 days, then fixed and immunolabeled with ZO-1 or occludin. Immunostaining for ZO-1 and occludin in
untreated or IL-22-treated ARPE-19 monolayer showed a continuous labeling in the region of cell-cell contact. Incubation with IL-17A or IL-17F
caused a marked disruption of ZO-1 and occludin staining. The immunostaining shown is representative of three independent experiments. Scale bar
=15mm.
doi:10.1371/journal.pone.0018139.g005
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Each experiment was repeated four times.
Immunocytochemistry
The expression of IL-17RA, IL-17RC and IL-22R (R&D
Systems, Minneapolis, MN) as well as the formation of tight
junction proteins in the ARPE-19 monolayer was examined by
immunocytochemistry. The staining of tight junction proteins
including occludin and ZO-1 was performed using the ARPE-19
cells cultured under conditions identical to these in the
permeability assay. ARPE-19 cells grown on coverslips or filters
were fixed with 4% paraformaldehyde in phosphate-buffered
saline (PBS) for 20 minutes at room temperature (RT) and rinsed
three times. The ARPE-19 cells cultured on coverslips were
directly used for the detection of IL-17RA, IL-17RC and IL-22R.
The ARPE-19 monolayer on filters was permeabilized by 0.2%
Triton X-100 in PBS for 20 minutes and used for the assay of tight
junction proteins. For the immunocytochemistry staining, the
ARPE-19 cells on coverslips or filters were incubated with 10%
goat or rabbit serum at RT for 30 minutes to exclude nonspecific
staining. These cells were then incubated with each of rabbit anti-
occludin, ZO-1 (Zymed-Invitrogen Carlsbad, CA), IL-17RC
antibodies, mouse anti-IL-22R or goat anti-IL-17RA antibodies
overnight at 4uC. Rabbit IgG, Mouse IgG1 or Goat IgG were used
as isotype controls. After washing with PBS for three times, the
cells were incubated with secondary antibody–labeled fluorescent
dye (Dylight 488, Dylight 594 or rhodamine; Jackson Immunor-
esearch Laboratories, West Grove, PA) for 30 minutes at RT and
then with DAPI for staining of nuclei for 2 minutes. Photographs
were taken by a laser confocal microscope (TCSSP2; Leica,
Germany).
Statistical Analysis
Student’s t-test was applied using SPSS 12.0. A p,0.05 was
considered significant for all experiments. Values were presented
as means6SEM.
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